Perioperative beta blockade not beneficial in diabetics undergoing non-cardiac surgery .
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial
BMJ. 2006 Jun 24;332(7556):1482.921 patients (>39 years) with either insulin- or non-insulin-dependent diabetes, scheduled to undergo major orthopaedic surgery were randomized to receive perioperative beta blockade (metoprolol) or a placebo. The primary purpose of this study was to determine whether the perioperative administration of metoprolol significantly improved the incidence of the following composite outcome: all-cause mortality, acute myocardial infarction, unstable angina, or congestive heart failure during hospital admission. Results indicated that the study drug did not significantly impact rates of mortality or cardiac complications in diabetic patients undergoing major non-cardiac surgery, when compared to a placebo. Older age, as well as the presence of coronary artery disease or malignant disease were significant predictors for the primary composite outcome following surgery.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
